← SynDRA
PEMRAMETOSTAT
SynDRA canonical compound SYN0039886 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | PRMT5 |
|---|
| Mechanism of action | protein arginine N-methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PRMT5 INHIBITOR
- Protein arginine N-methyltransferase 5 inhibitor
- protein arginine N-methyltransferase inhibitor
Drug classes
Cross-references
Synonyms
- Gsk-3326595
- GSK3326595
- EPZ-015938
- EPZ015938
- GSK-3326595A
- JLCCNYVTIWRPIZ-NRFANRHFSA-N
- 6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamide
- SCHEMBL15825290
- MolPort-044-813-754
- BDBM178166
- AKOS030528008
- ZINC220119494
- CS-6451
- AS-53150
- HY-101563
- GSK3326595(EPZ015938)
- US9675614, 208
- (S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
- Gsk 3326595
- VXT8SZ6875
- PROTEIN ARGININE METHYLTRANSFERASE 5 INHIBITOR GSK3326595
- RefChem:170734
- PRMT5 Inhibitor GSK3326595
- MFCD29991177
- A1BLM
- PEMRAMETOSTAT [INN]
- UNII-VXT8SZ6875
- EPZ015938(pemrametostat)?
- PEMRAMETOSTAT [WHO-DD]
- SCHEMBL29412225
- SCHEMBL29756965
- GTPL13679
- Pemrametostat (GSK3326595)
- EBC-09060
- NSC800404
- s8664
- CCG-269258
- NSC-800404
- AC-38013
Look up PEMRAMETOSTAT in the interactive SynDRA portal →